A Los Angeles-based developer of master-planned communities that counts the California Public Employees' Retirement System as a significant stakeholder entered Chapter 11 Sunday, in what it characterized as an effort to restructure its debt for the long term.
Microsoft Corp., Dell Inc. and Avon Products Inc. were just some of the companies that hired law firms to work on major IP litigation in recent weeks, according to our daily review of court dockets.
A New Jersey jury has handed consumers a $6 million victory in a product liability class action alleging that certain models of Kia Motors America Inc.'s Sephia had defective brakes.
Dr Reddy's Laboratories Ltd. has asked a district court to issue a declaratory judgment of noninfringement, as the battle over the Indian generics maker's bid to market a knockoff version of AstraZeneca AB's best-selling heartburn treatment continues to unfold.
An appeals court has shot down a bid by consumer class representatives in the multidistrict litigation over average wholesale drug prices to reverse a judge’s declaration that their attorneys are unfit to serve as co-lead counsel, ruling that disqualification orders are not appealable.
Responding to last year's scare over contact lens cleaners causing users to suffer potentially blinding infections, the U.S. Food and Drug Administration is now considering a series of new regulations that would affect how contact lens products are tested and labeled.
Re/Max International Inc., Microsoft Corp. and Mylan Inc. were just some of the companies that hired law firms to work on major IP litigation in recent weeks, according to our daily review of court dockets.
The New Jersey Supreme Court has sided with Merck & Co. Inc. in the pharmaceutical giant's argument that it is not responsible for medical monitoring costs for Vioxx users who haven't claimed to be injured by the drug.
Auditors and cheese mongers entwined in shareholder litigation stemming from an accounting scandal at now-bankrupt New Jersey cheese retailer Suprema Specialties Inc. have won a dismissal of the third-party claims against them.
Utility regulators from four Middle Atlantic states have filed a complaint alleging that electricity users in the region serviced by PJM Interconnection LLC will pay about $12 billion in unreasonable capacity charges over the next three years.
In a move to protect the market for the hypertension drug Azor, Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. on Tuesday hit Mylan Inc. with a patent infringement suit.
The new coal-fired unit at Duke Energy Carolinas' Cliffside Steam Station will have to meet more stringent limits on air pollutants rather than looser standards in place when the project was originally approved, the North Carolina Department of Environment and Natural Resources said Monday.
Aetna Inc.'s proposal to provide health care coverage for eating disorders as part of a settlement has been hailed by a lawyer for the class plaintiffs as a “landmark” but has been termed a “sham” by counsel for a separate plaintiff in the purported class action the deal is meant to settle.
In a dispute over how much Coin Acceptors Inc. owes Mars Inc. for infringing patents for coin recognition technology, the U.S. Court of Appeals for the Federal Circuit has reversed part of a lower court's ruling about Mars' claim to the patents at issue, shaving off seven years from the damages period.
Sanofi-Aventis, Microscan Systems Inc. and Otsuka Pharmaceutical were just some of the companies that hired law firms to work on major IP litigation in recent weeks, according to our daily review of court dockets.
Would-be class action plaintiffs in a case claiming Altana Pharma AG and Wyeth fraudulently obtained a patent for ulcer drug Protonix in order to maintain a monopoly have lost their bid to obtain discovery from another case challenging the patent's validity.
A proposed class and collective action has been filed against Wells Fargo & Co. alleging that the bank wrongfully classified its technical support workers as exempt from overtime and owes them compensation.
Merck & Co Inc. crafted its $4.85 billion Vioxx settlement despite winning 12 of 17 jury verdicts over the painkiller. Although appeals courts have recently overturned two of those verdicts, lowered damages in a third case and rejected medical monitoring claims in still another, many legal pundits agree with Merck that settling before the appellate rulings was ultimately the right decision.
US Bancorp Equipment Finance Inc., Sepracor Inc. and Nikon Inc. were just some of the companies that hired law firms to work on major IP litigation in recent weeks, according to our daily review of court dockets.
Appeals courts in Texas and New Jersey have lifted more than $36 million in court awards against Merck & Co. Inc. from early lawsuits over painkiller Vioxx.